剖宫产瘢痕缺陷:一种患病率急剧上升的医源性病理的管理
全球约20%孕妇接受剖宫产且剖宫产率持续上升,剖宫产瘢痕缺陷(CSD)尚无正常与异常的统一界定。有剖宫产史且出现点滴出血、痛经、盆腔痛或不孕者应怀疑CSD,可用多种影像学检查诊断。治疗包括激素药物和手术,术式选择需考虑症状严重程度、生育意愿、CSD大小及残余肌层厚度(RMT)。
要点
- 有剖宫产史且出现点滴出血、痛经、盆腔痛或不孕者应怀疑CSD。
- RMT<3 mm且有生育要求者禁忌宫腔镜手术,需腹腔镜或阴道途径修补。
- 治疗决策前应向患者提供完整信息,包括现有文献证据。
核心结论
- CSD是一种患病率急剧上升的医源性病理,其正常与异常界定尚不明确。
- 有剖宫产史且出现点滴出血、痛经、盆腔痛或不孕者应怀疑CSD。
- 治疗需根据症状严重程度、生育意愿、CSD大小及RMT个体化选择。
- 预防优于治疗,应早期识别危险因素并适当管理。
研究设计与样本
- 本文为综述,总结CSD的定义、诊断、治疗及预防。
主要发现
- 全球约20%孕妇接受剖宫产,多数地区剖宫产率持续上升。
- CSD可通过子宫输卵管造影、经阴道超声、盐水灌注超声造影、宫腔镜和磁共振成像显示。
- 对无再生育意愿且无禁忌证者,可考虑激素治疗作为症状性治疗。
- 药物治疗失败或有禁忌时,应根据症状严重程度、是否希望保留子宫、CSD大小及RMT测量考虑手术。
- 宫腔镜更倾向于切除而非修补,RMT<3 mm且有生育要求者应排除该技术,需腹腔镜或阴道途径修补。
关键数值与推荐
- RMT<3 mm且有生育要求者,禁忌宫腔镜手术,应行腹腔镜或阴道途径修补。
- 约20%孕妇接受剖宫产。
临床怎么用
- 对有剖宫产史且出现点滴出血、痛经、盆腔痛或不孕者应怀疑CSD并进行影像学评估。
- 无再生育意愿且无禁忌证者,可考虑激素治疗作为症状性治疗。
- 有生育要求且RMT<3 mm者,应选择腹腔镜或阴道途径修补而非宫腔镜。
- 治疗决策前应向患者提供完整信息,包括现有文献证据。
局限性
- CSD的正常与异常界定尚不明确。
- 本文为综述,未报告原始研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Around 20% of pregnant women undergo cesarean section (CS), and in most regions of the world CS rates continue to grow. There is still no clear definition of what is considered a normal physiologic aspect of a CS scar and what is abnormal. Cesarean scar defects (CSDs) should be suspected in women presenting with spotting, dysmenorrhea, pelvic pain, or infertility and a history of CS. CSDs can be visualized with the use of hysterosalpingography, transvaginal sonography, saline infusion sonohysterography, hysteroscopy, and magnetic resonance imaging. It is reasonable to consider hormone therapy for CSDs as a symptomatic treatment in women who no longer wish to conceive and have no contraindications. In case of failure of or contraindications to medical treatment, surgery should be contemplated according to the severity of symptoms, including infertility, the desire or otherwise to preserve the uterus, the size of the CSD, and residual myometrium thickness (RMT) measurement. Hysteroscopy is considered to be more of a resection than a repair, so women who desire pregnancy should be excluded from this technique if the RMT is <3 mm, in which case repair is essential and can be achieved by only laparoscopic or vaginal approach. Women with CSDs need to be given complete information, including available literature, before any treatment decision is made. Because prevention is better than cure, risk factors should be identified early to ensure appropriate management.
引用
- Donnez O. Cesarean scar defects: management of an iatrogenic pathology whose prevalence has dramatically increased. Fertil Steril. 2020. PMID: 32228874. doi:10.1016/j.fertnstert.2020.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。